Quick Answer
STANDARD BIOTOOLS INC. reported Research And Development Expense of $25.99 million for the year ending 2025.
- STANDARD BIOTOOLS INC. showed a decrease of -9.9% in Research And Development Expense from 2024 to 2025.
- This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2003 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $3.45 million | Q3 2010: $3.46 million | Q1 2011: $3.22 million | Q2 2011: $3.42 million | Q3 2011: $3.29 million | Q1 2012: $4.28 million | Q2 2012: $3.99 million | Q3 2012: $4.07 million | Q1 2013: $4.20 million | Q2 2013: $5.00 million | Q3 2013: $5.00 million | Q1 2014: $7.65 million | Q2 2014: $11.37 million | Q3 2014: $12.69 million | Q1 2015: $9.99 million | Q2 2015: $10.09 million | Q3 2015: $9.44 million | Q1 2016: $10.41 million | Q2 2016: $9.98 million | Q3 2016: $9.25 million | Q1 2017: $8.52 million | Q2 2017: $7.46 million | Q3 2017: $7.68 million | Q1 2018: $7.26 million | Q2 2018: $7.39 million | Q3 2018: $7.43 million | Q1 2019: $8.37 million | Q2 2019: $7.87 million | Q3 2019: $7.13 million | Q1 2020: $8.70 million | Q2 2020: $8.45 million | Q3 2020: $8.13 million | Q1 2021: $10.75 million | Q2 2021: $9.44 million | Q3 2021: $9.21 million | Q1 2022: $8.87 million | Q2 2022: $12.61 million | Q3 2022: $8.49 million | Q1 2023: $6.43 million | Q2 2023: $6.18 million | Q3 2023: $6.37 million | Q1 2024: $15.98 million | Q2 2024: $7.24 million | Q3 2024: $6.94 million | Q1 2025: $11.33 million | Q2 2025: $6.22 million | Q3 2025: $6.36 million.
- Over the full 18 years of available data (2003 to 2025), STANDARD BIOTOOLS INC.'s Research And Development Expense has grown by 103,848.0%.
- Historical annual values: Fiscal year 2025: $25.99 million | Fiscal year 2024: $28.83 million | Fiscal year 2023: $25.95 million | Fiscal year 2022: $37.38 million | Fiscal year 2021: $37.94 million | Fiscal year 2020: $36.46 million | Fiscal year 2019: $31.64 million | Fiscal year 2018: $30.03 million | Fiscal year 2017: $30.83 million | Fiscal year 2016: $38.42 million | Fiscal year 2015: $39.26 million | Fiscal year 2014: $43.42 million | Fiscal year 2013: $19.95 million | Fiscal year 2012: $16.60 million | Fiscal year 2011: $13.94 million | Fiscal year 2010: $13.01 million | Fiscal year 2009: $12.32 million | Fiscal year 2003: $25.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: